← Back to Search

Toothpaste

Toothpaste 1 for Tooth Sensitivity

N/A
Waitlist Available
Led By Bennett T Amaechi, BDS, MS, PhD
Research Sponsored by The University of Texas Health Science Center at San Antonio
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up week 0 (baseline), 4 weeks and 8 weeks
Awards & highlights

Study Summary

This trial will test 3 different strengths of toothpaste to see which is most effective at reducing dental hypersensitivity.

Eligible Conditions
  • Tooth Sensitivity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~week 0 (baseline), 4 weeks and 8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and week 0 (baseline), 4 weeks and 8 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Measurement of Cold Air Stimulus
Secondary outcome measures
Measurement of Tactile Stimulus

Trial Design

3Treatment groups
Active Control
Placebo Group
Group I: Toothpaste 1Active Control2 Interventions
Toothpaste 3 containing 5% potassium nitrate (KNO3) will be used by subjects to brush their teeth twice daily for 3 minutes in the morning and before bed each night using a 1 inch strip of toothpaste on a soft-bristled toothbrush.
Group II: Toothpaste 2Active Control1 Intervention
Toothpaste 2 containing 15% nano-HAP will be used by subjects to brush their teeth twice daily for 3 minutes in the morning and before bed each night using a 1 inch strip of toothpaste on a soft-bristled toothbrush.
Group III: Toothpaste 3Placebo Group2 Interventions
Toothpaste 1 containing 0% nano-hydroxyapatite (HAP) will be used by subjects to brush their teeth twice daily for 3 minutes in the morning and before bed each night using a 1 inch strip of toothpaste on a soft-bristled toothbrush.

Find a Location

Who is running the clinical trial?

Sangi Co., Ltd.UNKNOWN
1 Previous Clinical Trials
203 Total Patients Enrolled
The University of Texas Health Science Center at San AntonioLead Sponsor
452 Previous Clinical Trials
91,222 Total Patients Enrolled
Bennett T Amaechi, BDS, MS, PhDPrincipal InvestigatorUniversity of Texas Health at San Antonio
4 Previous Clinical Trials
396 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who meets the qualifications for participation in this clinical investigation?

"With the objective of recruiting 178 patients, this research is open to those between 20 and 80 years old who suffer from dentin sensitivity."

Answered by AI

Is the target demographic for this experiment inclusive of individuals aged eighty-five and above?

"According to the eligibility requirements, individuals aged 20-80 are allowed to take part in this clinical trial. In addition, there exist 83 studies for those below 18 and 156 research projects for seniors above 65 years of age."

Answered by AI

Are there any open enrollment opportunities for this research endeavor?

"Contrary to popular belief, clinicaltrials.gov indicates that this experiment is not actively recruiting patients. Initially posted on July 28th 2020 and last updated September 8th 2022, the trial has concluded its recruitment process at present though there are 257 other studies with open enrollment."

Answered by AI
~41 spots leftby Apr 2025